admin, Author at Purespring Therapeutics

Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer

Appointments of Fredrik and Peter complete build-out of senior team. London— 6 September 2023 Purespring Therapeutics, a pioneering gene therapy company focused on transforming the…

admin In Press Releases

Purespring strengthens senior leadership with appointment of Chief Medical Officer and Chief Development Officer

Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, announces the appointments of Dr Ronny Renfurm as Chief Medical…

admin In Press Releases

Purespring Therapeutics and SwanBio Therapeutics announce licensing agreement for use of FunSel screening platform

FunSel is Purespring’s proprietary in-vivo ‘gene search engine’, which allows functional selection of therapeutic factors unconstrained by previous drug discovery bias SwanBio will use FunSel…

admin In Press Releases

Syncona founds Purespring with a £45m Series A Financing

Syncona Ltd, a leading healthcare company focused on founding, building and funding a portfolio of global leaders in life science, announces the foundation of a…